ASRT vs DAL · rev $125.0M vs P/E 12, rev $61.64B
Assertio Therapeutics Inc (ASRT) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
ASRT currently screens at market cap $151.5M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the ASRT and DAL stock pages for the full models.
Not investment advice.